Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_provenance.
- NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_assertion description "[Interferon-alpha (IFN-alpha) is one of the central agents in immunotherapy for renal cell carcinoma (RCC) and binds to the IFN-alpha receptor (IFNAR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_provenance.
- NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_assertion evidence source_evidence_literature NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_provenance.
- NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_assertion SIO_000772 17697365 NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_provenance.
- NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_assertion wasDerivedFrom befree-2016 NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_provenance.
- NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_assertion wasGeneratedBy ECO_0000203 NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_provenance.
- befree-2016 importedOn "2016-02-19" NP624920.RAC9IUWD0VaDWXb8zq6nm8F6MtVUE0u7w0xuq7rdmV984130_provenance.